9658 — Business Brain Showa-Ota Balance Sheet
0.000.00%
- ¥31bn
- ¥24bn
- ¥34bn
- 77
- 70
- 88
- 93
Annual balance sheet for Business Brain Showa-Ota, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7,144 | 8,966 | 9,042 | 11,326 | 11,015 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,627 | 5,856 | 7,945 | 7,773 | 6,224 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 14,019 | 15,966 | 18,453 | 20,711 | 18,013 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,654 | 2,046 | 4,680 | 3,906 | 3,398 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 20,651 | 22,786 | 28,296 | 30,393 | 44,715 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6,153 | 6,968 | 8,687 | 9,980 | 8,048 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,385 | 12,156 | 15,404 | 15,435 | 15,748 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 9,266 | 10,630 | 12,892 | 14,958 | 28,967 |
Total Liabilities & Shareholders' Equity | 20,651 | 22,786 | 28,296 | 30,393 | 44,715 |
Total Common Shares Outstanding |